In the future, robots could take blood samples, benefiting patients and healthcare workers alike. A team has created a blood-sampling robot that performed as well or better than people, according to the first human clinical trial of an automated blood drawing and testing device. More details
Materials called perovskites show strong potential for a new generation of solar cells, but they’ve had trouble gaining traction in a market dominated by silicon-based solar cells. Now, a study by researchers at MIT and elsewhere outlines a roadmap for how this promising technology could move from the laboratory to a significant place in the global solar market. The “technoeconomic” analysis shows that by starting with higher-value niche markets and gradually expanding, solar panel manufacturers could avoid the very steep initial capital costs that would be required to make perovskite-based panels directly competitive with silicon for large utility-scale installations at the outset. Rather than making a prohibitively expensive initial investment, of hundreds of millions or even billions of dollars, to build a plant for utility-scale production, the team found that starting with more specialized applications could be accomplished for more realistic initial capital investment on the order of $40 million. Continue reading Researchers develop a roadmap for growth of new solar cells
This is a guest post. The views expressed here are solely those of the author and do not represent positions of IEEE Spectrum or the IEEE. In my mythical free time outside of professorhood, I’m a stand-up comedian and improviser. As a comedian, I’ve often found myself wishing I could banter with modern commercial AI assistants. They don’t have enough comedic skills for my taste! This longing for cheeky AI eventually led me to study autonomous robot comedians, and to teach my own robot how to perform stand-up.